Cardiac Biotech Solutions, Inc. (CBSC)
0.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Cardiac Biotech Solutions Shareholders Equity (Quarterly) : -2.221M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.221M |
| March 31, 2026 | -2.294M |
| December 31, 2025 | -2.230M |
| September 30, 2025 | -1.980M |
| June 30, 2025 | -2.106M |
| March 31, 2025 | -1.957M |
| December 31, 2024 | -1.599M |
| September 30, 2024 | -1.159M |
| June 30, 2024 | -0.8607M |
| March 31, 2024 | -0.6428M |
| December 31, 2023 | -0.6469M |
| September 30, 2023 | -0.6691M |
| June 30, 2023 | -0.5522M |
| March 31, 2023 | -0.3769M |
| December 31, 2022 | -0.1178M |
| September 30, 2022 | 0.0804M |
| June 30, 2022 | 0.0722M |
| March 31, 2022 | 0.4891M |
| December 31, 2021 | 1.670M |
| September 30, 2021 | -1.281M |
| June 30, 2021 | -1.204M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.1899M |
| December 31, 2020 | 17.58M |
| September 30, 2020 | 17.31M |
| June 30, 2020 | 17.45M |
| March 31, 2020 | -1.966M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -1.074M |
| March 31, 2019 | -1.032M |
| December 31, 2018 | -1.381M |
| September 30, 2018 | -1.430M |
| June 30, 2018 | -1.319M |
| March 31, 2018 | -1.214M |
| December 31, 2017 | -1.102M |
| September 30, 2017 | -0.7192M |
| June 30, 2017 | -0.6446M |
| March 31, 2017 | -0.5181M |
| December 31, 2016 | 1.546M |
| September 30, 2016 | 1.599M |
| June 30, 2016 | 1.953M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vyome Holdings, Inc. | 6.048M |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.5053M |
| Total Liabilities (Quarterly) | 2.726M |
| Debt to Equity Ratio | -0.2375 |
| Current Ratio | 0.2327 |
| Net Debt Paydown Yield | -1.03% |